| AA | anthranilic acid |
| Acetyl-CoA | acetyl coenzyme A |
| ACMS | 2-amino-3-carboxymuconate semialdehyde |
| ACMSD | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase |
| acyl-CoA | acyl coenzyme A |
| AD | Alzheimer’s disease |
| ADHD | attention-deficit hyperactive disorder |
| AHR | aryl hydrocarbon receptor |
| ALS | amyotrophic lateral sclerosis |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| AMS | 2-aminomuconic-6-semialdehyde |
| AMSD | 2-aminomuconate semialdehyde dehydrogenase |
| Aβ | amyloid beta |
| ASD | autism spectrum disorder |
| ATP | adenosine triphosphate |
| BAC | bacterial artificial chromosome |
| BCG | Bacillus Calmette-Guérin |
| BD | bipolar disorder |
| BPA | bisphenol A |
| BSSG | beta-sitosterol beta-d-glucoside |
| CA | cinnabarinic acid |
| CMS | chronic mild stress |
| C9orf72 | chromosome 9 open reading frame 72 |
| Cys | cysteine |
| EAE | experimental autoimmune/allergic encephalomyelitis |
| ER | endoplasmic reticulum |
| ETC | electron transport chain |
| FA | Friedreich’s ataxia |
| FADH2 | flavin adenine dinucleotide |
| FVB | Friend leukemia virus B |
| GABA | gamma-aminobutyric acid |
| GAD | generalized anxiety disorder |
| GTP | guanosine triphosphate |
| GPR35 | G-protein-coupled receptor 35 |
| H+ | proton |
| HD | Huntington’s disease |
| 5-HT | serotonin |
| i.c.v. | intracerebroventricular |
| IDO | indoleamine 2,3-dioxygenase |
| IDO1 | indoleamine 2,3-dioxygenase isoform 1 |
| IDO2 | indoleamine 2,3-dioxygenase isoform 2 |
| 3-HAA | 3-hydroxyanthranilic acid |
| 3-HK | 3-hydroxy-L-kynurenine |
| 3-HAO | 3-hydroxyanthranilate oxidase |
| HTT | huntingtin |
| 5-HTT | 5-HT transporter |
| iPSC | induced pluripotent stem cells |
| KAT | kynurenine aminotransferase |
| KFA | kynurenine formamidase |
| KI | knock-in |
| KMO | kynurenine 3-monooxygenase |
| KO | knockout |
| KYN | kynurenine |
| KYNA | Kynurenic acid |
| KYNU | kynureninase |
| MDD | major depressive disorder |
| MELAS | mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes |
| MPT | mitochondrial permeability transition |
| MS | multiple sclerosis |
| mtDNA | mitochondrial DNA |
| MTF | mitofusin |
| NaAD | nicotinic acid adenine dinucleotide |
| NADH | nicotinamide adenine dinucleotide |
| NaMN | nicotinic acid mononucleotide |
| nDNA | nuclear DNA |
| NDUFS2 | NADH:Ubiquinone Oxidoreductase Core Subunit S2 |
| NMDA | N-methyl-D-aspartic acid |
| NMS | non-motor symptoms |
| OCD | obsessive-compulsive disorder |
| OXPHOS | oxidative phosphorylation |
| parkin | Parkinson juvenile disease protein 2 |
| Pi | inorganic phosphate |
| PINK1 | phosphatase and tensin homolog (PTEN)-induced kinase1 |
| PD | Parkinson’s diseases |
| PFC | prefrontal cortex |
| PIC | picolinic acid |
| PLP | pyridoxal 5’-phosphate |
| PMD | primary mitochondrial disease |
| PMM | primary mitochondrial myopathy |
| PTSD | post-traumatic stress disorder |
| QPRT | quinolinate phosphoribosyltransferase |
| QUIN | quinolinic acid |
| RCS | reactive chemical species |
| SCZ | schizophrenia |
| SNP | single-nucleotide polymorphism |
| SMD | secondary mitochondrial dysfunction |
| SOD1 | superoxide dismutase 1 |
| SSRI | selective serotonin reuptake inhibitor |
| succinyl-CoA | succinyl coenzyme A |
| SUD | substance use disorder |
| TDP-43 | transactive response (TAR) DNA binding protein 43 kDa |
| TDO | tryptophan 2,3-dioxygenase |
| TPH | tryptophan hydroxylase |
| Trp | tryptophan |
| TST | tail suspension test |
| XA | xanthurenic acid |